Lei Tommy Fu (Tommy Fu, Lei Fu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Chronic Lymphocytic Leukemia

Oxide Nanoparticles

Top Venues

Clinical and translational science

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Hengbang Wang, Yun Yang, Zi Chen, Lei Tommy Fu, Min Yu, Lixin Jiang, Cunlin Wang, Lichuang Men, Ilisse Minto, Dajun Yang, Yifan Zhai
Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers. Clinical and translational science 17 (9) (2024)
Hengbang Wang, Yun Yang, Zi Chen, Lei Tommy Fu, Min Yu, Lixin Jiang, Cunlin Wang, Lichuang Men, Ilisse Minto, Dajun Yang, Yifan Zhai
Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers. Clinical and translational science 17 (9) (2024)
Nehal J Lakhani, Drew W Rasco, Hengbang Wang, Lichuang Men, Eric Liang, Lei Tommy Fu, Mary C Collins, Ping Min, Yan Yin, Matthew S Davids, Dajun Yang, Yifan Zhai
First-in-Human Study with preclinical data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sikandar Ailawadhi, Zi Chen, Bo Huang, Aneel Paulus, Mary C Collins, Lei Tommy Fu, Mingyu Li, Mohammad Ahmad, Lichuang Men, Hengbang Wang, Matthew S Davids, Eric Liang, Divya J Mekala, Zhicong He, Masa Lasica, Costas K Yannakou, Ricardo D Parrondo, Laura Glass, Dajun Yang, Asher A Chanan-Khan, Yifan Zhai
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)